Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection
Completed · Phase 1
Conditions studied: Corneal Ulcers
In brief
This study will evaluate the Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes with Corneal Infection. The treatment of UV-X system is to use the eyedrops of the riboflavin, also known as vitamin B2, and ultraviolet A (UVA) light. The eye drops are placed in affected eye and then affected cornea is exposed to UVA. UVA/riboflavin corneal collagen cross-linking was first used to treat patients in 1998 in Dresden, Germany. Data to date obtained mostly by physicians outside the United States has strongly suggested this treatment as an acceptable alternative, and many subjects have had a lasting effect (no progression) 3-5 years after their initial treatment.
Key facts
- Study ID
- NCT02068430
- Run by
- Stephen Trokel
- People needed
- 6
- Starts
- 2008-11-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2023-02-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Subjects who have one eye that meets the following criteria:
- 18 years of age or older
- Having a diagnosis of a corneal ulcer.
- Corneal scraping sent for cultures and sensitivities.
- Having been treated for at least three days with conventional broad spectrum anti infective therapy without improvement
- Showing no response to the therapy by one or more of the following criteria:
- Progressive thinning of cornea
- Increasing diameter of corneal ulcer
- Increasing diameter of corneal infiltrate
- Persistent epithelial defect
- Persistent inflammatory signs as iritis and hypopyon
- Persistent pain
You may not qualify if…
- All subjects meeting any of the following criteria will be excluded from this study:
- A corneal ulcer that has perforated
- A corneal ulcer that has produced a descemetocele.
- Women who may be breast-feeding and pregnant women.
- Herpetic infection suggested by history or clinical evaluation.
Where it is running
- Harkness Eye Institute Columbia University — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.